16 Recruiting Glioblastoma Phase 1 / Phase 2 Clinical Trials
Active phase 1 / phase 2 studies for glioblastoma enrolling across the USA. Verify eligibility and contact site coordinators.
All Glioblastoma studiesPhase 1 / Phase 2 Studies for Glioblastoma
A Phase 1-2 Study of ST101 in Patients With Advanced Solid Tumors
📍 University of California, San Francisco — San Francisco, California
View Study & Checklist ➔Radiation/Temozolomide and Immunotherapy With Daratumumab to Improve Antitumor Efficacy in Glioblastoma
📍 West Virginia University Cancer Institute Mary Babb Randolph Cancer Center — Morgantown, West Virginia
View Study & Checklist ➔A Phase 1b / 2 Drug Resistant Immunotherapy With Activated, Gene Modified Allogeneic or Autologous γδ T Cells (DeltEx) in Combination With Maintenance Temozolomide in Subjects With Recurrent or Newly Diagnosed Glioblastoma
📍 University of Alabama at Birmingham — Birmingham, Alabama
View Study & Checklist ➔Ultrasound-based Blood-brain Barrier Opening and Albumin-bound Paclitaxel and Carboplatin for Recurrent Glioblastoma
📍 Northwestern Memorial Hospital — Chicago, Illinois
View Study & Checklist ➔INO-5401 and INO-9012 Delivered by Electroporation (EP) in Combination With Cemiplimab (REGN2810) in Newly-Diagnosed Glioblastoma (GBM)
📍 City of Hope — Duarte, California
View Study & Checklist ➔A Study Using Radiation Therapy and Temozolomide to Treat Glioblastoma in Patients Over 70
📍 James Graham Brown Cancer Center — Louisville, Kentucky
View Study & Checklist ➔Ph I/II Study of NMS-03305293+TMZ in Adult Patients With Recurrent Glioblastoma
📍 Mayo Clinic Hospital - Phoenix — Phoenix, Arizona
View Study & Checklist ➔Short Course Chemo-Radiation Therapy for Patients With Newly Diagnosed Glioblastoma
📍 University of Pittsburgh Medical Center, Radiation Oncology — Pittsburgh, Pennsylvania
View Study & Checklist ➔A Phase 1/2 Study of Safety and Tolerability of MT-125 With Chemoradiation in Patients With Newly Diagnosed MGMT Methylated Glioblastoma
📍 Mayo Clinic Hospital — Phoenix, Arizona
View Study & Checklist ➔Combination ADI-PEG 20, TMZ, and RT for Treatment of Newly Diagnosed High-grade Glioma (HGG)
📍 University of California, San Francisco — San Francisco, California
View Study & Checklist ➔Study of Liposomal Curcumin in Combination With RT and TMZ in Patients With Newly Diagnosed High-Grade Gliomas
📍 Sibley Memorial Hospital — Washington D.C., District of Columbia
View Study & Checklist ➔Safety and Efficacy of CTX-009 With or Without CTX-471 for Recurrent Glioblastoma
📍 Washington University School of Medicine — St Louis, Missouri
View Study & Checklist ➔A Phase I/II Study of IVONESCIMAB in Recurrent Glioblastoma
📍 The University of Texas M. D. Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma
📍 Lenox Hill Brain Tumor Center — New York, New York
View Study & Checklist ➔HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBM
📍 Houston Methodist Neurological Institute — Houston, Texas
View Study & Checklist ➔Verteporfin for the Treatment of Recurrent High Grade EGFR-Mutated Glioblastoma
📍 Emory University Hospital/Winship Cancer Institute — Atlanta, Georgia
View Study & Checklist ➔